A proteomics-based identification of putative biomarkers for disease in bovine milk

被引:19
|
作者
van Altena, S. E. C. [1 ]
de Klerk, B. [2 ]
Hettinga, K. A. [3 ]
van Neerven, R. J. J. [1 ,4 ]
Boeren, S. [5 ]
Savelkoul, H. F. J. [1 ]
Tijhaar, E. J. [1 ]
机构
[1] Wageningen Univ, Cell Biol & Immunol Grp, POB 338, NL-6700 EV Wageningen, Netherlands
[2] Wageningen Univ, Anim Breeding & Genom Ctr, POB 338, NL-6700 EV Wageningen, Netherlands
[3] Wageningen Univ, Dairy Sci & Technol Grp, NL-6700 EV Wageningen, Netherlands
[4] FrieslandCampina, Stn Pl 4, NL-3818 LE Amersfoort, Netherlands
[5] Wageningen Univ, Biochem Lab, NL-6700 EV Wageningen, Netherlands
关键词
Dairy cattle; Biomarker; Lactoferrin; Milk; ACUTE-PHASE PROTEINS; SOMATIC-CELL COUNT; GAMMA-GLUTAMYL-TRANSFERASE; DAIRY-CATTLE; CLINICAL MASTITIS; EARLY LACTATION; ENERGY-BALANCE; SAMPLE PREPARATION; HOOF DISEASES; MAMMARY-GLAND;
D O I
10.1016/j.vetimm.2016.04.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to identify and characterize potential biomarkers for disease resistance in bovine milk that can be used to indicate dairy cows at risk to develop future health problems. We selected high- and low-resistant cows i.e. cows that were less or more prone to develop diseases according to farmers' experience and notifications in the disease registration data. The protein composition of milk serum samples of these high- and low-resistant cows were compared using NanoLC-MS/MS. In total 78 proteins were identified and quantified of which 13 were significantly more abundant in low-resistant cows than high-resistant cows. Quantification of one of these proteins, lactoferrin (LF), by ELISA in a new and much larger set of full fat milk samples confirmed higher LF levels in low- versus high-resistant cows. These high- and low-resistant cows were selected based on comprehensive disease registration and milk recording data, and absence of disease for at least 4 weeks. Relating the experienced diseases to LF levels in milk showed that lameness was associated with higher LF levels in milk. Analysis of the prognostic value of LF showed that low-resistant cows with higher LF levels in milk had a higher risk of being culled within one year after testing than high-resistant cows. In conclusion, LF in milk are higher in low-resistant cows, are associated with lameness and may be a prognostic marker for risk of premature culling. (C) 2016 The Authors. Published by Elsevier B.V.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [1] Proteomics-Based Biomarkers in Chronic Obstructive Pulmonary Disease
    Chen, Hong
    Wang, Diane
    Bai, Chunxue
    Wang, Xiangdong
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (06) : 2798 - 2808
  • [2] Identification of biomarkers for colorectal cancer through proteomics-based approaches
    Tjalsma, Harold
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 879 - 895
  • [3] Plaque array method and proteomics-based identification of biomarkers from Alzheimer's disease serum
    Madasamy, Shanmugavel
    Chaudhuri, Vaishali
    Kong, Raymond
    Alderete, Benjamin
    Adams, Christopher M.
    Knaak, Tim D.
    Ruan, Weiming
    Wu, Alan H. B.
    Bigos, Marty
    Amento, Edward P.
    CLINICA CHIMICA ACTA, 2015, 441 : 79 - 85
  • [4] Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma
    Tung, Chun-Liang
    Lin, Szu-Ting
    Chou, Hsiu-Chuan
    Chen, Yi-Wen
    Lin, Hwan-Chung
    Tung, Chung-Liang
    Huang, Kao-Jean
    Chen, Yi-Ju
    Lee, Ying-Ray
    Chan, Hong-Lin
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 75 : 7 - 17
  • [5] Plasma proteomics-based identification of novel biomarkers in early gastric cancer
    Zhou, Bin
    Zhou, Zhe
    Chen, Yuling
    Deng, Haiteng
    Cai, Yunlong
    Rao, Xiaolong
    Yin, Yuxin
    Rong, Long
    CLINICAL BIOCHEMISTRY, 2020, 76 : 5 - 10
  • [6] Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers
    Masuda, Takeshi
    Mori, Ayano
    Ito, Shingo
    Ohtsuki, Sumio
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 36
  • [7] Proteomics-based development of biomarkers in cardiovascular disease - Mechanistic, clinical, and therapeutic insights
    Mayr, Manuel
    Zhang, Jun
    Greene, Andrew S.
    Gutterman, David
    Perloff, Joseph
    Ping, Peipei
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : 1853 - 1864
  • [8] Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer
    Sun, Zujun
    Ji, Shurong
    Wu, Junlu
    Tian, Jiale
    Quan, Wenqiang
    Shang, Anquan
    Ji, Ping
    Xiao, Weidong
    Liu, Ding
    Wang, Xuan
    Li, Dong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer
    Bai, Zhigang
    Ye, Yingjiang
    Liang, Bin
    Xu, Feng
    Zhang, Hui
    Zhang, Yanbin
    Peng, Jiarou
    Shen, Danhua
    Cui, Zhirong
    Zhang, Zhongtao
    Wang, Shan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (02) : 375 - 383
  • [10] LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study
    Liang, Hengrui
    Wang, Runchen
    Cheng, Ran
    Ye, Zhiming
    Zhao, Na
    Zhao, Xiaohong
    Huang, Ying
    Jiang, Zhanpeng
    Li, Wangzhong
    Zheng, Jianqi
    Deng, Hongsheng
    Jiang, Yu
    Lin, Yuechun
    Yan, Yun
    Song, Lei
    Li, Jie
    Xu, Xin
    Liang, Wenhua
    Liu, Jun
    He, Jianxing
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (01):